277 related articles for article (PubMed ID: 24429132)
1. Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases.
Serisier DJ
Lancet Respir Med; 2013 May; 1(3):262-74. PubMed ID: 24429132
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
Bush A
Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
[TBL] [Abstract][Full Text] [Related]
3. Long-term macrolide treatment for chronic respiratory disease.
Spagnolo P; Fabbri LM; Bush A
Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Amsden GW
J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
[TBL] [Abstract][Full Text] [Related]
5. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Shimizu T; Suzaki H
Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
[TBL] [Abstract][Full Text] [Related]
6. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
7. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
[TBL] [Abstract][Full Text] [Related]
8. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Shteinberg M; Schneer S; Lavon O; Adir Y
Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
[TBL] [Abstract][Full Text] [Related]
9. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis?
King P
Drugs; 2007; 67(7):965-74. PubMed ID: 17488142
[TBL] [Abstract][Full Text] [Related]
11. Role of long term antibiotics in chronic respiratory diseases.
Suresh Babu K; Kastelik J; Morjaria JB
Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
[TBL] [Abstract][Full Text] [Related]
12. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
[TBL] [Abstract][Full Text] [Related]
13. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
Crowley S; Egan JJ
Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
[TBL] [Abstract][Full Text] [Related]
14. Impact of Long-Term Erythromycin Therapy on the Oropharyngeal Microbiome and Resistance Gene Reservoir in Non-Cystic Fibrosis Bronchiectasis.
Choo JM; Abell GCJ; Thomson R; Morgan L; Waterer G; Gordon DL; Taylor SL; Leong LEX; Wesselingh SL; Burr LD; Rogers GB
mSphere; 2018 Apr; 3(2):. PubMed ID: 29669883
[TBL] [Abstract][Full Text] [Related]
15. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis.
Schultz MJ
J Antimicrob Chemother; 2004 Jul; 54(1):21-8. PubMed ID: 15190022
[TBL] [Abstract][Full Text] [Related]
16. Macrolide antibiotics and the risk of cardiac arrhythmias.
Albert RK; Schuller JL;
Am J Respir Crit Care Med; 2014 May; 189(10):1173-80. PubMed ID: 24707986
[TBL] [Abstract][Full Text] [Related]
17. Use of macrolides in lung diseases: recent literature controversies.
Silva Filho LV; Pinto LA; Stein RT
J Pediatr (Rio J); 2015; 91(6 Suppl 1):S52-60. PubMed ID: 26354869
[TBL] [Abstract][Full Text] [Related]
18. Macrolides in cystic fibrosis.
McArdle JR; Talwalkar JS
Clin Chest Med; 2007 Jun; 28(2):347-60. PubMed ID: 17467553
[TBL] [Abstract][Full Text] [Related]
19. Macrolides in cystic fibrosis.
Bell SC; Senini SL; McCormack JG
Chron Respir Dis; 2005; 2(2):85-98. PubMed ID: 16279156
[TBL] [Abstract][Full Text] [Related]
20. Macrolides and airway inflammation in children.
Shinkai M; Rubin BK
Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
